By 2030, millions of people could be saved thanks to new vaccines for cancer, cardiovascular and autoimmune diseases. This is the conviction of experts and pharmaceutical companies who are committed to this challenge, also helped by the great work done on the occasion of the Covid epidemic.
According to Paul Burton, chief medical officer at Moderna, treatments for "all kinds of conditions" will be available in just 5 years. "We will have the cancer vaccine and it will be highly effective and save hundreds of thousands, if not millions of lives. I think we will be able to offer personalised cancer vaccines against different types of cancer to people around the world," he said in an interview with the Guardian.
"The lessons learned from the Covid-19 vaccine development process have influenced our overall approach to mRNA research and development and how we conduct research and development more broadly. We gained a decade of scientific knowledge in just one year."
Advances, accelerated, but could be wasted if a high level of investment is not maintained, the researchers warned, worried that the threat of a widening conflict in Europe could drain attention and funds.